Category

Cohort News

New Research Validating VeraBIND™ Tau Assay as Accurate Blood Test for Active Tau Pathology in Alzheimer’s Disease Presented at the 2025 Alzheimer’s Association International Conference featuring Veravas Inc.

//
Categories
Developed by Veravas Inc., VeraBIND™ Tau Assay is the first blood-based test that measures pathologically active tau for the early detection of Alzheimer’s disease in both asymptomatic and symptomatic individuals AUSTIN, Texas, July 28, 2025 /PRNewswire/ — Veravas Inc., an...
Read More →

NEMBO-02 study indicates rapid cSDH resorption and pain-free treatments with NeoCast liquid embolic agent featuring Arsenal Medical

//
Categories
Arsenal Medical has announced late-breaking data from the EMBO-02 clinical study evaluating NeoCast—a next-generation, shear-responsive liquid embolic agent—in the treatment of patients with chronic subdural haematoma (cSDH) via middle meningeal artery embolisation (MMAe). Research presented across multiple sessions at the...
Read More →
1 2 3 133